Pharmacy Benefit Managers Lobbying Pays Off as Congressional Reform Stalls

Washington, DC – Lobbying efforts by pharmacy benefit managers (PBMs) saw success as Congress failed to impose any regulations on their operations this spring. The Pharmaceutical Care Management Association, the largest trade group representing PBMs, significantly increased its lobbying spending by 71% in the first quarter of the year, from $2.8 million to $4.8 million. Despite the initial push for transparency and reforms in the PBM industry, the House passed a bill advocating for more …

Read more

Recall: Robitussin Cough Syrup Recalled – Senate Considers Subpoena for Pharmacy CEOs

WASHINGTON, D.C. – The healthcare industry continues to face challenges and scrutiny, as senators confront drug-industry CEOs and political concerns impede infectious-disease help in certain regions. In the House, Rep. Michael Burgess of Texas, a senior physician in Congress, discusses his Health Care Task Force and the focus on health policy issues in his final year in the lower chamber. Burgess emphasizes the importance of addressing the cost of breakthrough drugs and the overall savings …

Read more